Suchergebnisse - "Boccadoro, Mario"

PubPharm (32)

1

Lenalidomide-based induction and maintenance in elderly newly diagnosed multiple myeloma patients : updated results of the EMN01 randomized trial

enthalten in: Haematologica | 2020

von Bringhen, S. | D'Agostino, M. | Paris, L. | +23

2

Autologous haematopoietic stem-cell transplantation versus bortezomib-melphalan-prednisone, with or without bortezomib-lenalidomide-dexamethasone consolidation therapy, and lenalidomide maintenance for newly diagnosed multiple myeloma (EMN02/HO95) : a multicentre, randomised, open-label, phase 3 study

enthalten in: The Lancet. Haematology | 2020

von Cavo, M. | Gay, F. | Beksac, M. | +57

CommentIn: Lancet Haematol. 2020 Jun;7(6):e427-e429. - PMID 32359505

3

First-line therapy with either bortezomib-melphalan-prednisone or lenalidomide-dexamethasone followed by lenalidomide for transplant-ineligible multiple myeloma patients : a pooled analysis of two randomized trials

enthalten in: Haematologica | 2020

von Larocca, A. | Mina, R. | Offidani, M. | +24

4

Daratumumab plus Bortezomib, Melphalan, and Prednisone for Untreated Myeloma

enthalten in: The New England journal of medicine | 2018

von Mateos, M. | Dimopoulos, M. | Cavo, M. | +127

5

Bortezomib, melphalan, and prednisone in elderly relapsed/refractory multiple myeloma patients : update of multicenter, open-label Phase 1/2 study

enthalten in: Leukemia & lymphoma | 2017

von Grammatico, S. | Bringhen, S. | Vozella, F. | +3

6

Chemotherapy plus lenalidomide versus autologous transplantation, followed by lenalidomide plus prednisone versus lenalidomide maintenance, in patients with multiple myeloma : a randomised, multicentre, phase 3 trial

enthalten in: The Lancet. Oncology | 2015

von Gay, F. | Oliva, S. | Petrucci, M. | +23

CommentIn: Lancet Oncol. 2015 Dec;16(16):1571-3. - PMID 26596669

7

Continuous Therapy Versus Fixed Duration of Therapy in Patients With Newly Diagnosed Multiple Myeloma

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2015

von Palumbo, A. | Gay, F. | Cavallo, F. | +25

8

Autologous transplantation and maintenance therapy in multiple myeloma

enthalten in: The New England journal of medicine | 2014

von Palumbo, A. | Cavallo, F. | Gay, F. | +24

CommentIn: N Engl J Med. 2014 Sep 4;371(10):961-2. - PMID 25184869

9

Bortezomib cumulative dose, efficacy, and tolerability with three different bortezomib-melphalan-prednisone regimens in previously untreated myeloma patients ineligible for high-dose therapy

enthalten in: Haematologica | 2014

von Mateos, M. | Bringhen, S. | Richardson, P. | +12

10

Bortezomib, melphalan, prednisone (VMP) versus melphalan, prednisone, thalidomide (MPT) in elderly newly diagnosed multiple myeloma patients : A retrospective case-matched study

enthalten in: American journal of hematology | 2014

von Morabito, F. | Bringhen, S. | Larocca, A. | +31